Menu

First Human Case of H7N4 Bird Flu Confirmed

The woman, a resident of southeast China, has since recovered.

Feb 15, 2018
Shawna Williams

ISTOCK, BLUEBERRIESA 68-year-old woman in Jiangsu Province, China, was admitted to a hospital on January 1 with what turned out to be a H7N4 bird flu virus infection, Hong Kong’s Centre for Health Protection announced yesterday (February 14). The patient, who had contact with live poultry before her symptoms started, is believed to be the first person infected by the H7N4 virus. She later recovered and was discharged.

According to the World Health Organization, influenza type A viruses (of which H7N4 is one type) are of public health concern because they have the potential to cause pandemics if they acquire the ability to be transmitted among humans. A different bird flu strain, H7N9, has killed at least 600 people in China since 2013, Reuters reports.

Hong Kong has reported 21 cases of H7N9 in humans, all traced to mainland China, the South China Morning Post reports. The warning from the territory’s health department, which comes at the start of Chinese New Year, urges visitors to the mainland to avoid contact with live or freshly-killed poultry.

January 2019

Cannabis on Board

Research suggests ill effects of cannabinoids in the womb

Marketplace

Sponsored Product Updates

Horizon Discovery extends CRISPR Screening Service to primary human T cells
Horizon Discovery extends CRISPR Screening Service to primary human T cells
Horizon Discovery Group plc (LSE: HZD) (“Horizon” or “the Company”), a global leader in gene editing and gene modulation technologies, today announced the extension of its CRISPR Screening Service to includeex vivoT lymphocytes. The service extension meets the requirements of immunology-based research in drug discovery,enabling new gene targets to be identified in biologically and potentially therapeutically relevant settings.
pIC50: The Advantages of Thinking Logarithmically
pIC50: The Advantages of Thinking Logarithmically
Watch this webinar from Collaborative Drug Discovery to learn about how using pIC50 helps you get a better sense of the relative potencies, calculate the correct mean of multiple values, and select better sampling doses.
WIN a VIAFLO 96/384 to supercharge your microplate pipetting!
WIN a VIAFLO 96/384 to supercharge your microplate pipetting!
INTEGRA Biosciences is offering labs the chance to win a VIAFLO 96/384 pipette. Designed to simplify plate replication, plate reformatting or reservoir-to-plate transfers, the VIAFLO 96/384 allows labs without the space or budget for an expensive pipetting robot to increase the speed and throughput of routine tasks.
FORMULATRIX® digital PCR technology to be acquired by QIAGEN
FORMULATRIX® digital PCR technology to be acquired by QIAGEN
FORMULATRIX has announced that their digital PCR assets, including the CONSTELLATION® series of instruments, is being acquired by QIAGEN N.V. (NYSE: QGEN, Frankfurt Stock Exchange: QIA) for up to $260 million ($125 million upfront payment and $135 million of milestones).  QIAGEN has announced plans for a global launch in 2020 of a new series of digital PCR platforms that utilize the advanced dPCR technology developed by FORMULATRIX combined with QIAGEN’s expertise in assay development and automation.